High levels of cytoplasmic HTLV-1 Tax mutant proteins retain a Tax-NF-κB-CBP ternary complex in the cytoplasm

Oncogene

Volumn 24, Issue 28, 2005, Pages 4521-4530

  Azran, Inbal ^a   Jeang, Kuan Teh ^b   Aboud, Mordechai ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

CBP; Cytoplasmic Tax mutants; HTLV 1; NF B; PKAc; Tax

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN; PROTEIN CBP; PROTEIN P300; TAX PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE TRANSPORT; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PROTEIN INTERACTION; T CELL LEUKEMIA; TRANSCRIPTION REGULATION;

CELL NUCLEUS; CREB-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOPLASM; GENE EXPRESSION; GENE PRODUCTS, TAX; HUMANS; I-KAPPA B PROTEINS; JURKAT CELLS; MULTIPROTEIN COMPLEXES; MUTATION; NF-KAPPA B; NUCLEAR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR RELA;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 22744447869     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208645     Document Type: Article

References (78)

1. Ariumi Y, Kaida A, Lin JY, Hirota M, Masui O, Yamaoka S, Taya Y and Shimotohno K. (2000). Oncogene, 19, 1491-1499.
2. Azran I, Schavinsky-Khrapunsky Y and Aboud M. (2004). Retrovirology, 1, 20.
3. Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA and Baldwin ASJ. (1992). Genes Dev., 6, 1899-1913.
4. Bex F and Gaynor RB. (1998). Methods, 16, 83-94.
5. Bex F, McDowall A, Burny A and Gaynor RB. (1997). J. Virol., 71, 3484-3497.
6. Bex F, Yin MJ, Burny A and Gaynor RB. (1998). Mol. Cell. Biol., 18, 2392-2405.
7. Brady J, Jeang KT, Duvall J and Khoury G. (1987). J. Virol., 61, 2175-2181.
8. Brown K, Park S, Kanno T, Franzoso G and Siebenlist U. (1993). Proc. Natl. Acad. Sci. USA, 90, 2532-2536.
9. Catley MC, Cambridge LM, Nasuhara Y, Ito K, Chivers JE, Beaton A, Holden NS, Bergmann MW, Barnes PJ and Newton R. (2004). J. Biol. Chem., 279, 18457-18466.
10. Chan HM and La Thangue NB. (2001). J. Cell. Sci., 114, 2363-2373.
11. Chen LF and Greene WC. (2003). J. Mol. Med., 81, 549-557.
12. Chu ZL, DiDonato JA, Hawiger J and Ballard DW. (1998). J. Biol. Chem., 273, 15891-15894.
13. Duran A, Diaz-Meco MT and Moscat J. (2003). EMBO J., 22, 3910-3918.
14. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y and Collins T. (1997). Proc. Natl. Acad. Sci. USA, 94, 2927-2932.
15. Giebler HA, Loring JE, van Orden K, Colgin MA, Garrus JE, Escudero KW, Brauweiler A and Nyborg JK. (1997). Mol. Cell. Biol., 17, 5156-5164.
16. Gitlin SD, Lindholm PF, Marriott SJ and Brady JN. (1991). J. Virol., 65, 2612-2621.
17. Harhaj EW and Sun SC. (1999). J. Biol. Chem., 274, 22911-22914.
18. Harrod R, Kuo YL, Tang Y, Yao Y, Vassilev A, Nakatani Y and Giam CZ. (2000). J. Biol Chem., 275, 11852-11857.
19. Hirai H, Fujisawa J, Suzuki T, Ueda K, Muramatsu M, Tsuboi A, Arai N and Yoshida M. (1992). Oncogene, 7, 1737-1742.
20. Hirai H, Suzuki T, Fujisawa J, Inoue J and Yoshida M. (1994). Proc. Natl. Acad. Sci. USA, 91, 3584-3588.
21. Iha H, Kibler KV, Yedavalli VRK, Peloponese JM, Haller K, Miyazato A, Kasai T and Jeang KT. (2003). Oncogene, 22, 8912-8923.
22. Inoue M, Matsuoka M, Yamaguchi K, Takatsuki K and Yoshida M. (1998). Jpn. J. Cancer Res., 89, 53-59.
23. Jeang KT. (2001). Cytokine Growth Factor Rev., 12, 207-217.
24. Jeang KT, Giam CZ, Majone F and Aboud M. (2004). J. Biol. Chem., 279, 31991-31994.
25. Jeang KT, Widen SG, Semmes OJT and Wilson SH. (1990). Science, 247, 1082-1084.
26. Jiang H, Lu H, Schiltz RL, Pise-Masison CA, Ogryzko VV, Nakatani Y and Brady JN. (1999). Mol. Cell. Biol., 19, 8136-8145.
27. Jin DY, Giordano V, Kibler KV, Nakano H and Jeang KT. (1999). J. Biol. Chem., 274, 17402-17405.
28. Karin M. (1999). Oncogene, 18, 6867-6874.
29. Karin M and Lin A. (2002). Nat. Immunol., 3, 221-227.
30. Kucharczak J, Simmons MJ, Fan Y and Gelinas C. (2003). Oncogene, 22, 8961-8982.
31. Kwok RP, Laurance ME, Lundblad JR, Goldman PS, Shih H, Connor LM, Marriott SJ and Goodman RH. (1996). Nature, 380, 642-646.
32. Lee FS, Peters RT, Dang LC and Maniatis T. (1998). Proc. Natl. Acad. Sci. USA, 95, 9319-9324.
33. Li XH, Fang X and Gaynor RB. (2001). J. Biol. Chem., 276, 4494-4500.
34. Ling L, Cao Z and Goeddel DV. (1998). Proc. Natl. Acad. Sci. USA, 95, 3792-3797.
35. Low KG, Dorner LF, Fernando DB, Grossman J, Jeang KT and Comb MJ. (1997). J. Virol., 71, 1956-1962.
36. Majone F and Jeang KT. (2000). J. Biol. Chem., 275, 32906-32910.
37. Majone F, Semmes OJ and Jeang KT. (1993). Virology, 193, 456-459.
38. Marriott SJ, Lemoine FJ and Jeang KT. (2002). J. Biomed. Sci., 9, 292-298.
39. Matsuoka M. (2003). Oncogene, 22, 5131-5140.
40. Miyake H, Suzuki T, Hirai H and Yoshida M. (1999). Virology, 253, 155-161.
41. Mori N, Morishita M, Tsukazaki T, Giam CZ, Kumatori A, Tanaka Y and Yamamoto N. (2000). Blood, 97, 2137-2144.
42. Mor-Vaknin N, Torgeman A, Galron D, Lochelt M, Flugel RM and Aboud M. (1997). Virology, 232, 337-344.
43. Murakami T, Hirai H, Suzuki T, Fujisawa J and Yoshida M. (1995). Virology, 206, 1066-1074.
44. Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H and Okumura K. (1998). Proc. Natl. Acad. Sci. USA, 95, 3537-3542.
45. Neuveut C and Jeang K. (2002). Front. Biosci., 7, d157-163.
46. Nicot C, Mahieux R, Opavsky R, Cereseto ALW, Brady JN and Franchini G. (2000). Oncogene, 19, 2155-2164.
47. Nicot C, Tie F and Giam CZ. (1998). J. Virol., 72, 6777-6784.
48. Pahl HL. (1999). Oncogene, 18, 6853-6866.
49. Petropoulos L, Lin R and Hiscott J. (1996). Virology, 225, 52-64.
50. Seiki M, Inoue J, Takeda T and Yoshida M. (1986). EMBO J., 5, 561-565.
51. Sheppard KA, Rose DW, Haque ZK, Kurokawa R, McInerney E, Westin S, Thanos D, Rosenfeld MG, Glass CK and Collins T. (1999). Mol. Cell. Biol., 19, 6367-6378.
52. Silverman N and Maniatis T. (2001). Genes Dev., 15, 2321-2342.
53. Smith MR and Green WC. (1990). Gene Dev., 4, 1875-1885.
54. Sun SC, Ganchi PA, Ballard DW and Greene WC. (1993). Science, 259, 1912-1915.
55. Suzuki T, Hirai H, Fujisawa J, Fujita T and Yoshida M. (1993). Oncogene, 8, 2391-2397.
56. Suzuki T, Hirai H and Yoshida M. (1994). Oncogene, 9, 3099-3105.
57. Suzuki T, Murakami T and Yoshida M. (1995). Oncogene, 10, 1199-1207.
58. Suzuki T, Uchida-Toita M and Yoshida M. (1999). Oncogene, 18, 4137-4143.
59. Tabakin-Fix Y, Huleihel M and Aboud M. (2004). Biochem. Biophys. Res. Commun., 318, 1052-1056.
60. Torgeman A, Ben-Aroya Z, Grunspan A, Zelin E, Butovsky E, Hallak M, Lochelt M, Flugel RM, Livneh E, Wolfson M, Kedar I and Aboud M. (2001a). Exp. Cell Res., 271, 169-179.
61. Torgeman A, Mor-Vaknin N, Zelin E, Ben-Aroya Z, Lochelt M, Flugel RM and Aboud M. (2001b). Virology, 281, 10-20.
62. Turgeman H and Aboud M. (1998). FEBS Lett., 428, 183-187.
63. Uhlik M, Good L, Xiao G, Harhaj EW, Zandi E, Karin M and Sun S-C. (1998). J. Biol. Chem., 273, 21132-21136.
64. Van Orden K and Nyborg JK. (2000). Gene Expr., 9, 29-36.
65. Van Orden K, Yan JP, Ulloa A and Nyborg JK. (1999). Oncogene, 18, 3766-3772.
66. Wang D, Westerheide SD, Hanson JL and Baldwin Jr. AS. (2000). J. Biol. Chem., 275, 32592-32597.
67. Wang T, Zhang X and Li JJ. (2002). Int. Immunopharmacol., 2, 1509-1520.
68. Whiteside ST and Israel A. (1997). Seminars Cancer Biol., 8, 75-82.
69. Yamamoto Y and Gaynor RB. (2001). J. Clin. Invest., 107, 135-142.
70. Yamaoka S, Inoue H, Sakurai M, Sugiyama T, Hazama M, Yamada T and Hatanaka M. (1996). EMBO J., 15, 873-887.
71. Yasunaga J and Matsuoka M. (2003). Int. J. Hematol., 78, 312-320.
72. Yin MJ, Christerson LB, Yamamoto Y, Kwak YT, Xu S, Mercurio F, Barbosa M, Cobb MH and Gaynor RB. (1998). Cell, 93, 875-884.
73. Yoshida M. (1994). Leukemia., 8 (Suppl 1), S51-S53.
74. Yoshida M. (1997). Leukemia., 11 (Suppl. 3), 1-2.
75. Yoshida M. (2001). Ann. Rev. Immunol., 19, 475-496.
76. Zandi E, Rothwarf DM, Delhase M, Hayakawa M and Karin M. (1997). Cell., 91, 243-252.
77. Zhong H, May MJ, Jimi E and Ghosh S. (2002). Mol. Cell., 9, 625-636.
78. Zhong H, Voll RE and Ghosh S. (1998). Mol. Cell., 1, 661-671.